Genitourinary Cancers

5 protocols meet the specified criteria.
  • A151804

    Establishment of a National Biorepository to Advance Studies of Immune-Related Adverse Events
  • EA8171

    Multiparametric MRI (mpMRI) for Preoperative Staging and Treatment Planning for Newly-Diagnosed Prostate Cancer (Phase II)
  • EAY191

    Molecular Analysis for Combination Therapy Choice (ComboMATCH)
  • S1802

    Phase III Randomized Trial of Standard Systemic Therapy (SST) Versus Standard Systemic Therapy Plus Definitive Treatment (Surgery or Radiation) of the Primary Tumor in Metastatic Prostate Cancer
  • S2013

    Immune Checkpoint Inhibitor Toxicity (I-CHECKIT): A Prospective Observational Study